Jiangsu Hansoh Pharmaceutical Group Co., Ltd. was established in July, 1995. It has developed into a new pharmaceutical group featuring R&D, manufacture, sales and pharmaceutical investment of drugs. There are more than 40 products launched into the market which cover six therapeutic categories: oncology, antibiotics, psychotropic, antidiabetics, gastro-intestinal and cardiovascular area.
Since its inception, Hansoh has evolved into a flagship enterprise for R&D and production in China, a Top 30 enterprise of China's Pharmaceutical Industry, and one of the most innovative pharmaceutical enterprises in China.
Adhering to the concept of management innovation, technology innovation and product innovation, Hansoh will accelerate collection and fusion of development factors including top-level talents, innovative technology and lean manufacturing, along with peers in the international pharmaceutical field, hand in hand and shoulder by shoulder, to jointly endeavor bravely to contribute wisdom and strength to health of mankind.
There is no investment information
No recent news or press coverage available for Jiangsu Hansoh Pharmaceutical Group Co., Ltd..
We care about your data, and we'd love to use cookies make your experience better.
